The University of Chicago Header Logo

Connection

Tamar Polonsky to Middle Aged

Back to Details
This is a "connection" page, showing publications Tamar Polonsky has written about Middle Aged.
Tamar Polonsky
Connection Strength
0.773
Middle Aged
  1. Discordance of patient-reported outcome measures with objectively assessed walking decline in peripheral artery disease. J Vasc Surg. 2024 Apr; 79(4):893-903.
    View in: PubMed
    Score: 0.053
  2. Perceived Versus Objective Change in Walking Ability in Peripheral Artery Disease: Results from 3 Randomized Clinical Trials of Exercise Therapy. J Am Heart Assoc. 2021 06 15; 10(12):e017609.
    View in: PubMed
    Score: 0.044
  3. Hospital Admissions for Myocardial Infarction and Stroke Before and After the Trans-Fatty Acid Restrictions in New York. JAMA Cardiol. 2017 06 01; 2(6):627-634.
    View in: PubMed
    Score: 0.033
  4. Association of Cardiovascular Health With Subclinical Disease and Incident Events: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2017 Mar 20; 6(3).
    View in: PubMed
    Score: 0.033
  5. Exercise Treadmill Testing. JAMA. 2015 Nov 10; 314(18):1968-9.
    View in: PubMed
    Score: 0.030
  6. High-risk plaque in the superficial femoral artery of people with peripheral artery disease: prevalence and associated clinical characteristics. Atherosclerosis. 2014 Nov; 237(1):169-76.
    View in: PubMed
    Score: 0.028
  7. Coronary artery calcium score. JAMA. 2014 Aug 27; 312(8):837-8.
    View in: PubMed
    Score: 0.028
  8. Coronary artery calcium testing: dos and don'ts. Cardiol Clin. 2012 Feb; 30(1):49-55.
    View in: PubMed
    Score: 0.023
  9. The contribution of early nephropathy to cardiovascular risk. Cardiol Clin. 2010 Aug; 28(3):427-36.
    View in: PubMed
    Score: 0.021
  10. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010 Apr 28; 303(16):1610-6.
    View in: PubMed
    Score: 0.020
  11. The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing. Atherosclerosis. 2009 Dec; 207(2):440-4.
    View in: PubMed
    Score: 0.019
  12. Nocturnal Oxygen Therapy for Central Sleep Apnea in Patients with Heart Failure: A Multisite, Double-Blind, Sham-controlled Randomized Clinical Trial (LOFT-HF). Ann Am Thorac Soc. 2025 Dec; 22(12):1951-1960.
    View in: PubMed
    Score: 0.015
  13. Transfusion Strategy Effect on Quality of Life in Patients With Myocardial Infarction and Anemia: A Secondary Analysis of the MINT Randomized Clinical Trial. JAMA Intern Med. 2025 Aug 01; 185(8):947-954.
    View in: PubMed
    Score: 0.015
  14. Association of study visit interval length with follow-up completeness and adherence to assigned study drug dose: A randomized comparison of participants in the ADAPTABLE trial. Contemp Clin Trials. 2025 Sep; 156:108030.
    View in: PubMed
    Score: 0.015
  15. Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemia. Am Heart J. 2025 Apr; 282:146-155.
    View in: PubMed
    Score: 0.014
  16. Hepatocyte growth factor for walking performance in peripheral artery disease. J Vasc Surg. 2025 Jun; 81(6):1467-1478.e1.
    View in: PubMed
    Score: 0.014
  17. The ankle-brachial index, gastrocnemius mitochondrial respirometry, and walking performance in people with and without peripheral artery disease. Vasc Med. 2024 12; 29(6):640-652.
    View in: PubMed
    Score: 0.014
  18. Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial. JAMA Cardiol. 2024 Sep 01; 9(9):808-816.
    View in: PubMed
    Score: 0.014
  19. Differing associations of PM2.5 exposure with systolic and diastolic blood pressures across exposure durations in a predominantly non-Hispanic Black cohort. Sci Rep. 2024 08 31; 14(1):20256.
    View in: PubMed
    Score: 0.014
  20. Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial. Circulation. 2024 Dec 03; 150(23):1826-1836.
    View in: PubMed
    Score: 0.014
  21. Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trial. BMJ Open. 2024 08 07; 14(8):e078197.
    View in: PubMed
    Score: 0.014
  22. Contextual Deprivation, Race and Ethnicity, and Income in Air Pollution and Cardiovascular Disease. JAMA Netw Open. 2024 08 01; 7(8):e2429137.
    View in: PubMed
    Score: 0.014
  23. Small dense low-density lipoprotein cholesterol and coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis. Eur J Prev Cardiol. 2024 Jun 03; 31(8):1048-1054.
    View in: PubMed
    Score: 0.014
  24. Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease. J Am Heart Assoc. 2024 Feb 20; 13(4):e026921.
    View in: PubMed
    Score: 0.013
  25. Home-Based Walking Exercise and Supervised Treadmill Exercise in Patients With Peripheral Artery Disease: An Individual Participant Data Meta-Analysis. JAMA Netw Open. 2023 09 05; 6(9):e2334590.
    View in: PubMed
    Score: 0.013
  26. Study Design, Rationale, and Methodology for Promote Weight Loss in Patients With Peripheral Artery Disease Who Also Have Obesity: The PROVE Trial. J Am Heart Assoc. 2023 09 05; 12(17):e031182.
    View in: PubMed
    Score: 0.013
  27. Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease: The TELEX Randomized Clinical Trial. JAMA. 2022 10 04; 328(13):1315-1325.
    View in: PubMed
    Score: 0.012
  28. Barriers to participation in supervised exercise therapy reported by people with peripheral artery disease. J Vasc Surg. 2023 Feb; 77(2):506-514.
    View in: PubMed
    Score: 0.012
  29. Urban Spatial Accessibility of Primary Care and Hypertension Control and Awareness on Chicago's South Side: A Study From the COMPASS Cohort. Circ Cardiovasc Qual Outcomes. 2022 09; 15(9):e008845.
    View in: PubMed
    Score: 0.012
  30. NT-pro B-type natriuretic peptide, early menopause, and incident heart failure in postmenopausal women of the ARIC study. Menopause. 2022 01 14; 29(3):309-316.
    View in: PubMed
    Score: 0.012
  31. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. N Engl J Med. 2021 05 27; 384(21):1981-1990.
    View in: PubMed
    Score: 0.011
  32. Optimal Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea Reduces Daytime Resting Heart Rate in Prediabetes: A Randomized Controlled Study. J Am Heart Assoc. 2020 10 20; 9(19):e016871.
    View in: PubMed
    Score: 0.011
  33. Clinical characteristics and response to supervised exercise therapy of people with lower extremity peripheral artery disease. J Vasc Surg. 2021 02; 73(2):608-625.
    View in: PubMed
    Score: 0.010
  34. Association of six-minute walk distance with subsequent lower extremity events in peripheral artery disease. Vasc Med. 2020 08; 25(4):319-327.
    View in: PubMed
    Score: 0.010
  35. Associations of Peripheral Artery Disease With Calf Skeletal Muscle Mitochondrial DNA Heteroplasmy. J Am Heart Assoc. 2020 04 07; 9(7):e015197.
    View in: PubMed
    Score: 0.010
  36. Patient-provider communications about pharmacogenomic results increase patient recall of medication changes. Pharmacogenomics J. 2019 12; 19(6):528-537.
    View in: PubMed
    Score: 0.009
  37. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018 10 23; 138(17):e595-e616.
    View in: PubMed
    Score: 0.009
  38. Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease: The HONOR Randomized Clinical Trial. JAMA. 2018 04 24; 319(16):1665-1676.
    View in: PubMed
    Score: 0.009
  39. Effect of Granulocyte-Macrophage Colony-Stimulating Factor With or Without Supervised Exercise on Walking Performance in Patients With Peripheral Artery Disease: The PROPEL Randomized Clinical Trial. JAMA. 2017 12 05; 318(21):2089-2098.
    View in: PubMed
    Score: 0.009
  40. Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing. Clin Pharmacol Ther. 2017 Nov; 102(5):859-869.
    View in: PubMed
    Score: 0.008
  41. Racial differences in functional decline in peripheral artery disease and associations with socioeconomic status and education. J Vasc Surg. 2017 09; 66(3):826-834.
    View in: PubMed
    Score: 0.008
  42. Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program. Clin Pharmacol Ther. 2017 07; 102(1):106-114.
    View in: PubMed
    Score: 0.008
  43. Plaque Composition in the Proximal Superficial Femoral Artery and Peripheral Artery Disease Events. JACC Cardiovasc Imaging. 2017 09; 10(9):1003-1012.
    View in: PubMed
    Score: 0.008
  44. Obesity and Cardiovascular Risk in Adults With Celiac Disease. J Clin Gastroenterol. 2016 08; 50(7):545-50.
    View in: PubMed
    Score: 0.008
  45. European Society of Cardiology-Recommended Coronary Artery Disease Consortium Pretest Probability Scores More Accurately Predict Obstructive Coronary Disease and Cardiovascular Events Than the Diamond and Forrester Score: The Partners Registry. Circulation. 2016 Jul 19; 134(3):201-11.
    View in: PubMed
    Score: 0.008
  46. Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment. J Am Coll Cardiol. 2016 Jan 19; 67(2):139-147.
    View in: PubMed
    Score: 0.008
  47. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines. Circulation. 2015 Sep 08; 132(10):916-22.
    View in: PubMed
    Score: 0.007
  48. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA. 2012 Aug 22; 308(8):788-95.
    View in: PubMed
    Score: 0.006
  49. Design of the value of imaging in enhancing the wellness of your heart (VIEW) trial and the impact of uncertainty on power. Clin Trials. 2012 Apr; 9(2):232-46.
    View in: PubMed
    Score: 0.006
  50. Automated border detection for assessing the mechanical properties of the carotid arteries: comparison with carotid intima-media thickness. J Am Soc Echocardiogr. 2010 May; 23(5):567-72.
    View in: PubMed
    Score: 0.005
  51. Diagnostic value of parametric imaging of left ventricular wall motion from contrast-enhanced echocardiograms in patients with poor acoustic windows. J Am Soc Echocardiogr. 2009 Mar; 22(3):276-83.
    View in: PubMed
    Score: 0.005
  52. Use of carotid intima-media thickness to identify patients with ischemic stroke and transient ischemic attack with low yield of cardiovascular sources of embolus on transesophageal echocardiography. Stroke. 2008 Nov; 39(11):2969-74.
    View in: PubMed
    Score: 0.005
  53. Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema. Chest. 2007 Apr; 131(4):964-71.
    View in: PubMed
    Score: 0.004
  54. Quantification of regional left ventricular wall motion from real-time 3-dimensional echocardiography in patients with poor acoustic windows: effects of contrast enhancement tested against cardiac magnetic resonance. J Am Soc Echocardiogr. 2006 Jul; 19(7):886-93.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.